\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\:\\ \\ bp\\ 120\\/77\\,\\ \\ hr\\ 92\\,\\ \\ t\\ 102\\.1\\,\\ \\ rr\\ 18\\,\\ \\ spo2\\ 98\\%\\ room\\ air\\,\\ \\ ht\\ 6\\â\\€\\™3\\â\\€\\™\\â\\€\\™\\,\\ \\ wt\\ 347\ \(0\)\
\-\ heent\\:\\ \\ no\\ notable\\ conjunctival\\ injection\\,\\ no\\ bleeding\\ or\\ lesions\\ noted\\ in\\ the\\ nostrils\\.\\ \\ mucous\\ membranes\\ were\\ appropriately\\ moist\\.\\ \\ no\\ oral\\ lesions\\.\\ \\ no\\ sinus\\ tenderness\\ to\\ palpation\\.\\ \\ no\\ lymphadenopathy\\.\ \(0\)\
\-\ cv\\:\\ \\ rrr\\.\\ \\ no\\ murmurs\\,\\ rubs\\,\\ gallops\\.\ \(0\)\
\-\ pulm\\:\\ \\ mild\\ crackles\\ noted\\ up\\ to\\ mid\\-lung\\ fields\\ bilaterally\\.\ \(0\)\
\-\ abd\\:\\ \\ non\\-tender\\,\\ non\\-distended\\,\\ no\\ organomegaly\\ noted\\.\\ \\ large\\,\\ scaly\\ plaque\\ on\\ the\\ lower\\ abdomen\\,\\ without\\ bleeding\\ or\\ erythema\\.\ \(0\)\
\-\ musc\\/skel\\:\\ \\ diffuse\\,\\ scaly\\ plaques\\ along\\ the\\ extensor\\ surfaces\\ of\\ the\\ forearms\\ and\\ lower\\ legs\\ bilaterally\\.\\ \\ full\\ range\\ of\\ motion\\ and\\ strength\\ bilaterally\\,\\ however\\ experienced\\ moderate\\ pain\\ with\\ movement\\.\ \(0\)\
\-\ neuro\\:\\ \\ cn\\ ii\\-xii\\ grossly\\ intact\\.\\ \\ no\\ apparent\\ deficits\\.\ \(0\)\
\-\ laboratory\\ data\\:\ \(0\)\
\-\ wbc\\:\\ 10\\.8\\ \\&\\#61664\\;\\ 12\\.2\\ \\(n\\ 84\\,\\ l\\ 7\\,\\ m\\ 8\\,\\ bands\\ 1\\)\ \(0\)\
\-\ sputum\\:\\ dark\\ brown\\,\\ blood\\ tinged\ \(0\)\
\-\ bacterial\\ cultures\\ \\-\\ neg\ \(0\)\
\-\ afb\\ smear\\ \\&\\ cultures\\ \\-\\ neg\ \(0\)\
\-\ fungal\\ wet\\ prep\\ \\-\\ neg\ \(0\)\
\-\ pneumocystis\\ direct\\ fluorescent\\ antibody\\ and\\ \\ giemsa\\ stain\\ \\-\\ neg\ \(0\)\
\-\ blood\ \(828\)\
\-\ cultures\\ for\\ afb\\,\\ fungal\\ \\-\\ neg\ \(0\)\
\-\ serum\\ cryptococcus\\ antigen\\ \\-\\ neg\ \(0\)\
\-\ mycoplasma\\ pneumoniae\\ serology\\ \\-\\ neg\ \(0\)\
\-\ urine\ \(118\)\
\-\ legionella\\ antigen\\ \\-\\ neg\ \(0\)\
\-\ ua\\ \\/\\ urine\\ culture\\ \\-\\ neg\ \(0\)\
\-\ hospital\\ course\\ \\/\\ discharge\\:\ \(0\)\
\-\ 14\\ days\\ of\\ moxifloxacin\\ therapy\\ for\\ presumed\\ cap\ \(0\)\
\-\ serum\\ c\\.\\ pneumoniae\\ titers\\ \\@\\ 2\\ week\\ follow\\-up\ \(0\)\
\-\ follow\\-up\\ ct\\ with\\ improvement\\ \\@\\ 6\\ weeks\ \(0\)\
\-\ chest\\ films\\ \\(a\\/p\\ \\&\\ lateral\\)\\:\\ \\ notable\\ infiltrative\\ process\\ in\\ the\\ left\\ lower\\ lobe\\,\\ with\\ increased\\ density\\ inferior\\ to\\ the\\ left\\ pulmonary\\ artery\\.\ \(0\)\
\-\ chest\\ ct\\ w\\/o\\ contrast\\:\\ prominent\\ left\\ lower\\ lobe\\ infiltrate\\ with\\ notable\\ air\\ bronchograms\\ suggestive\\ of\\ an\\ infectious\\ process\\.\\ \\ diffuse\\ mediastinal\\ lymphadenopathy\\ is\\ also\\ present\\.\ \(0\)\
\-\ chlamydophila\\ pneumonia\\ in\\ an\\ idiopathic\\ cd4\\+\\ lymphocytopenic\\ patient\ \(0\)\
\-\ community\\ acquired\\ pneumonia\ \(9\)\
\-\ atypical\\ pneumonia\ \(1\)\
\-\ tuberculosis\\ \\/\\ ntm\ \(0\)\
\-\ pcp\ \(0\)\
\-\ aspergillosis\ \(15\)\
\-\ primary\\ lung\\ neoplasm\ \(1\)\
\-\ sarcoidosis\ \(108\)\
\-\ pulmonary\\ embolism\ \(77\)\
\-\ cc\\:\\ cough\\ x\\ 1\\ week\ \(0\)\
\-\ hpi\\:\ \(0\)\
\-\ \\â\\€\\˜deep\\â\\€\\™\\ cough\\ productive\\ of\\ dark\\ brown\\ sputum\ \(0\)\
\-\ daily\\ fevers\\ to\\ 102f\\ with\\ chills\ \(0\)\
\-\ epistaxis\\ x\\ 3\\-4\\ weeks\ \(0\)\
\-\ 2\\-3x\\ per\\ week\ \(2\)\
\-\ each\\ episode\\ lasting\\ about\\ 10\\ minutes\ \(0\)\
\-\ no\\ attempt\\ at\\ treatment\\,\\ including\\ otc\\ meds\ \(0\)\
\-\ no\\ associated\\ shortness\\ of\\ breath\\,\\ dyspnea\\ or\\ chest\\ pain\ \(0\)\
\-\ atypical\\ pneumonia\\ in\\ icl\\ patients\\ has\\ not\\ been\\ well\\ described\\.\\ \\ empiric\\ therapy\\ typically\\ calls\\ for\\ quinolone\\ antibiotics\\ to\\ address\\ the\\ most\\ common\\ typical\\ and\\ atypical\\ organisms\\ seen\\ in\\ community\\ acquired\\ pneumonias\\.\\ \\ as\\ is\\ the\\ case\\ in\\ most\\ c\\.\\ pneumoniae\\ infections\\,\\ the\\ bacteria\\ are\\ often\\ difficult\\ to\\ isolate\\,\\ and\\ treatment\\ regimens\\ are\\ often\\ completed\\ with\\ full\\ resolution\\ of\\ disease\\ without\\ ever\\ having\\ confirmed\\ the\\ causative\\ organism\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neg\\:\\ 0\\.10040084300552984\ \(0\)\
\-\ pneumoniae\\:\\ 0\\.0410508943571522\ \(0\)\
\-\ \\:\\:\\ 0\\.03614951437070357\ \(0\)\
\-\ \\-\\:\\ 0\\.03515043950613064\ \(0\)\
\-\ scaly\\:\\ 0\\.032907915289118926\ \(0\)\
\-\ notable\\:\\ 0\\.03019940636510276\ \(0\)\
\-\ pneumonia\\:\\ 0\\.03012635134523249\ \(0\)\
\-\ cultures\\:\\ 0\\.02812373869618273\ \(0\)\
\-\ \\/\\:\\ 0\\.026996152924297922\ \(0\)\
\-\ \\@\\:\\ 0\\.02665487874842201\ \(0\)\
\-\ community\\:\\ 0\\.02665487874842201\ \(0\)\
\-\ antigen\\:\\ 0\\.02633885328081552\ \(0\)\
\-\ afb\\:\\ 0\\.025510895863156854\ \(0\)\
\-\ brown\\:\\ 0\\.02404036074037762\ \(0\)\
\-\ atypical\\:\\ 0\\.02368996142181208\ \(0\)\
\-\ sputum\\:\\ 0\\.023233358609722914\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.021782744048148877\ \(0\)\
\-\ c\\.\\:\\ 0\\.02108450922413052\ \(0\)\
\-\ dark\\:\\ 0\\.01992487717515977\ \(0\)\
\-\ acquired\\:\\ 0\\.0195369378224701\ \(0\)\
\-\ \\&\\:\\ 0\\.01919864323331406\ \(0\)\
\-\ 120\\/77\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ nostrils\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ musc\\/skel\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ giemsa\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ moxifloxacin\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ chlamydophila\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ lymphocytopenic\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ icl\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ calls\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ quinolone\\:\\ 0\\.018796414550035178\ \(0\)\
\-\ week\\:\\ 0\\.018562998411481204\ \(0\)\
\-\ no\\:\\ 0\\.01834635715786358\ \(0\)\
\-\ bilaterally\\:\\ 0\\.017953338412732858\ \(0\)\
\-\ fungal\\:\\ 0\\.017666053686586743\ \(0\)\
\-\ serum\\:\\ 0\\.017587081201438613\ \(0\)\
\-\ urine\\:\\ 0\\.017587081201438613\ \(0\)\
\-\ 102\\.1\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 347\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 61664\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ tinged\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ fluorescent\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ ntm\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 102f\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ 2\\-3x\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ isolate\\:\\ 0\\.017318488791911626\ \(0\)\
\-\ mid\\-lung\\:\\ 0\\.016453957644559463\ \(0\)\
\-\ cd4\\+\\:\\ 0\\.016453957644559463\ \(0\)\
\-\ lower\\:\\ 0\\.016391147713124627\ \(0\)\
\-\ bleeding\\:\\ 0\\.015819074413927152\ \(0\)\
\-\ full\\:\\ 0\\.01574223643736989\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.015495671103089182\ \(0\)\
\-\ 12\\.2\\:\\ 0\\.0153647772100904\ \(0\)\
\-\ forearms\\:\\ 0\\.014976031886435912\ \(0\)\
\-\ prep\\:\\ 0\\.014976031886435912\ \(0\)\
\-\ otc\\:\\ 0\\.014976031886435912\ \(0\)\
\-\ pneumonias\\:\\ 0\\.014976031886435912\ \(0\)\
\-\ \\,\\:\\ 0\\.01443017406808568\ \(0\)\
\-\ cryptococcus\\:\\ 0\\.014362637275664525\ \(0\)\
\-\ legionella\\:\\ 0\\.014362637275664525\ \(0\)\
\-\ titers\\:\\ 0\\.014362637275664525\ \(0\)\
\-\ a\\/p\\:\\ 0\\.014362637275664525\ \(0\)\
\-\ 10\\.8\\:\\ 0\\.014111500739083748\ \(0\)\
\-\ serology\\:\\ 0\\.014111500739083748\ \(0\)\
\-\ hpi\\:\\ 0\\.014111500739083748\ \(0\)\
\-\ empiric\\:\\ 0\\.014111500739083748\ \(0\)\
\-\ process\\:\\ 0\\.014030129999295158\ \(0\)\
\-\ cough\\:\\ 0\\.013962707372315872\ \(0\)\
\-\ conjunctival\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ wet\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ \\â\\€\\˜\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ regimens\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ ever\\:\\ 0\\.01388685145196685\ \(0\)\
\-\ mycoplasma\\:\\ 0\\.013683631452384068\ \(0\)\
\-\ address\\:\\ 0\\.013683631452384068\ \(0\)\
\-\ pneumocystis\\:\\ 0\\.013327439374211004\ \(0\)\
\-\ lasting\\:\\ 0\\.013327439374211004\ \(0\)\
\-\ causative\\:\\ 0\\.013327439374211004\ \(0\)\
\-\ smear\\:\\ 0\\.01316942664040776\ \(0\)\
\-\ epistaxis\\:\\ 0\\.01316942664040776\ \(0\)\
\-\ chest\\:\\ 0\\.013079289979045962\ \(0\)\
\-\ noted\\:\\ 0\\.012955785853641323\ \(0\)\
\-\ 92\\:\\ 0\\.012755447931578427\ \(0\)\
\-\ aspergillosis\\:\\ 0\\.012755447931578427\ \(0\)\
\-\ bronchograms\\:\\ 0\\.0126335749809602\ \(0\)\
\-\ spo2\\:\\ 0\\.012518293059275177\ \(0\)\
\-\ organism\\:\\ 0\\.012518293059275177\ \(0\)\
\-\ ht\\:\\ 0\\.012408925693843298\ \(0\)\
\-\ air\\:\\ 0\\.012329478151607532\ \(0\)\
\-\ pulm\\:\\ 0\\.012110925816710765\ \(0\)\
\-\ antibody\\:\\ 0\\.012110925816710765\ \(0\)\
\-\ x\\:\\ 0\\.012021604841567066\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.011855168407001031\ \(0\)\
\-\ surfaces\\:\\ 0\\.011849513616087453\ \(0\)\
\-\ ii\\-xii\\:\\ 0\\.011849513616087453\ \(0\)\
\-\ wt\\:\\ 0\\.01169150088228421\ \(0\)\
\-\ productive\\:\\ 0\\.01169150088228421\ \(0\)\
\-\ often\\:\\ 0\\.011626752872152035\ \(0\)\
\-\ organomegaly\\:\\ 0\\.011616679304861457\ \(0\)\
\-\ cap\\:\\ 0\\.011616679304861457\ \(0\)\
\-\ moist\\:\\ 0\\.011544394546491135\ \(0\)\
\-\ pcp\\:\\ 0\\.011544394546491135\ \(0\)\
\-\ bacteria\\:\\ 0\\.011544394546491135\ \(0\)\
\-\ 84\\:\\ 0\\.011474480212113758\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.011406785759417422\ \(0\)\
\-\ appropriately\\:\\ 0\\.011341174546908353\ \(0\)\
\-\ 98\\:\\ 0\\.011277522173454875\ \(0\)\
\-\ stain\\:\\ 0\\.011215715058586534\ \(0\)\
\-\ meds\\:\\ 0\\.011215715058586534\ \(0\)\
\-\ organisms\\:\\ 0\\.011040367301151627\ \(0\)\
\-\ diffuse\\:\\ 0\\.011032014585822238\ \(0\)\
\-\ plaque\\:\\ 0\\.010984982468735293\ \(0\)\
\-\ extensor\\:\\ 0\\.010984982468735293\ \(0\)\
\-\ 6\\:\\ 0\\.010883241626332087\ \(0\)\
\-\ gallops\\:\\ 0\\.010878350441923647\ \(0\)\
\-\ bands\\:\\ 0\\.010878350441923647\ \(0\)\
\-\ infiltrate\\:\\ 0\\.010826969734932046\ \(0\)\
\-\ membranes\\:\\ 0\\.010679863399138973\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.010679863399138973\ \(0\)\
\-\ pulmonary\\:\\ 0\\.010646269979616475\ \(0\)\
\-\ crackles\\:\\ 0\\.010587144610354883\ \(0\)\
\-\ n\\:\\ 0\\.010587144610354883\ \(0\)\
\-\ mucous\\:\\ 0\\.010498290247027444\ \(0\)\
\-\ completed\\:\\ 0\\.010498290247027444\ \(0\)\
\-\ rubs\\:\\ 0\\.010455214112022071\ \(0\)\
\-\ infiltrative\\:\\ 0\\.010455214112022071\ \(0\)\
\-\ attempt\\:\\ 0\\.010455214112022071\ \(0\)\
\-\ weeks\\:\\ 0\\.010342335850324727\ \(0\)\
\-\ presumed\\:\\ 0\\.010330973369753468\ \(0\)\
\-\ w\\/o\\:\\ 0\\.010291118075484485\ \(0\)\
\-\ plaques\\:\\ 0\\.010175836153799463\ \(0\)\
\-\ cv\\:\\ 0\\.010102304861536841\ \(0\)\
\-\ blood\\:\\ 0\\.009946315874240082\ \(0\)\
\-\ fields\\:\\ 0\\.009928860001293872\ \(0\)\
\-\ legs\\:\\ 0\\.009863248788784803\ \(0\)\
\-\ data\\:\\ 0\\.009863248788784803\ \(0\)\
\-\ lobe\\:\\ 0\\.009805225364279463\ \(0\)\
\-\ murmurs\\:\\ 0\\.009799596415331324\ \(0\)\
\-\ cn\\:\\ 0\\.009799596415331324\ \(0\)\
\-\ cc\\:\\ 0\\.00976846891123505\ \(0\)\
\-\ lesions\\:\\ 0\\.009755055464153294\ \(0\)\
\-\ therapy\\:\\ 0\\.009742604674800055\ \(0\)\
\-\ culture\\:\\ 0\\.009707544876173098\ \(0\)\
\-\ ua\\:\\ 0\\.009677723464713097\ \(0\)\
\-\ abd\\:\\ 0\\.009648313396200656\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.009648313396200656\ \(0\)\
\-\ grossly\\:\\ 0\\.009562441543028075\ \(0\)\
\-\ experienced\\:\\ 0\\.009453074177596197\ \(0\)\
\-\ daily\\:\\ 0\\.009426586928132322\ \(0\)\
\-\ each\\:\\ 0\\.009426586928132322\ \(0\)\
\-\ minutes\\:\\ 0\\.009426586928132322\ \(0\)\
\-\ neuro\\:\\ 0\\.009400424683800096\ \(0\)\
\-\ m\\:\\ 0\\.009400424683800096\ \(0\)\
\-\ bacterial\\:\\ 0\\.00932381059163365\ \(0\)\
\-\ rr\\:\\ 0\\.009298872340539424\ \(0\)\
\-\ rrr\\:\\ 0\\.009298872340539424\ \(0\)\
\-\ movement\\:\\ 0\\.009109218852231331\ \(0\)\
\-\ chills\\:\\ 0\\.009109218852231331\ \(0\)\
\-\ episode\\:\\ 0\\.009020364488903893\ \(0\)\
\-\ erythema\\:\\ 0\\.0089560722966423\ \(0\)\
\-\ embolism\\:\\ 0\\.008914263189204397\ \(0\)\
\-\ hr\\:\\ 0\\.008873258153110821\ \(0\)\
\-\ discharge\\:\\ 0\\.008833026843293372\ \(0\)\
\-\ heent\\:\\ 0\\.008813192317360935\ \(0\)\
\-\ vital\\:\\ 0\\.008716696386469418\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.008679288476765988\ \(0\)\
\-\ 1\\:\\ 0\\.008670901355904934\ \(0\)\
\-\ fevers\\:\\ 0\\.008660827788614357\ \(0\)\
\-\ infections\\:\\ 0\\.008660827788614357\ \(0\)\
\-\ dyspnea\\:\\ 0\\.00862437910341329\ \(0\)\
\-\ direct\\:\\ 0\\.00860638578007456\ \(0\)\
\-\ without\\:\\ 0\\.008580013502593433\ \(0\)\
\-\ injection\\:\\ 0\\.008501502530200846\ \(0\)\
\-\ improvement\\:\\ 0\\.008501502530200846\ \(0\)\
\-\ t\\:\\ 0\\.008434341193187263\ \(0\)\
\-\ most\\:\\ 0\\.008412943035087744\ \(0\)\
\-\ having\\:\\ 0\\.00836923090777131\ \(0\)\
\-\ deficits\\:\\ 0\\.00833740649366326\ \(0\)\
\-\ l\\:\\ 0\\.008306050102640454\ \(0\)\
\-\ idiopathic\\:\\ 0\\.008306050102640454\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.008229619118049546\ \(0\)\
\-\ strength\\:\\ 0\\.008084515784904524\ \(0\)\
\-\ apparent\\:\\ 0\\.008056643542756651\ \(0\)\
\-\ 14\\:\\ 0\\.00802913095248819\ \(0\)\
\-\ per\\:\\ 0\\.007975148419472647\ \(0\)\
\-\ difficult\\:\\ 0\\.007975148419472647\ \(0\)\
\-\ bp\\:\\ 0\\.007909537206963576\ \(0\)\
\-\ 18\\:\\ 0\\.007909537206963576\ \(0\)\
\-\ resolution\\:\\ 0\\.007858464198386834\ \(0\)\
\-\ room\\:\\ 0\\.007833379248323748\ \(0\)\
\-\ infectious\\:\\ 0\\.007833379248323748\ \(0\)\
\-\ suggestive\\:\\ 0\\.007784077718641758\ \(0\)\
\-\ described\\:\\ 0\\.007759847956061128\ \(0\)\
\-\ mediastinal\\:\\ 0\\.00773589044376491\ \(0\)\
\-\ oral\\:\\ 0\\.007677148542340112\ \(0\)\
\-\ shortness\\:\\ 0\\.007665591895283951\ \(0\)\
\-\ films\\:\\ 0\\.00752079188330909\ \(0\)\
\-\ prominent\\:\\ 0\\.0074781465385187484\ \(0\)\
\-\ treatment\\:\\ 0\\.007375765286144508\ \(0\)\
\-\ deep\\:\\ 0\\.0073751218535063655\ \(0\)\
\-\ range\\:\\ 0\\.007335266559237384\ \(0\)\
\-\ motion\\:\\ 0\\.007325418060609891\ \(0\)\
\-\ typical\\:\\ 0\\.007305856490724941\ \(0\)\
\-\ moderate\\:\\ 0\\.007164599805136027\ \(0\)\
\-\ \\#\\:\\ 0\\.00714645334528974\ \(0\)\
\-\ about\\:\\ 0\\.007023576772077296\ \(0\)\
\-\ 7\\:\\ 0\\.006981353686157936\ \(0\)\
\-\ course\\:\\ 0\\.006875333568135696\ \(0\)\
\-\ hospital\\:\\ 0\\.006859480735539708\ \(0\)\
\-\ confirmed\\:\\ 0\\.0068515983008247275\ \(0\)\
\-\ antibiotics\\:\\ 0\\.006843744899084223\ \(0\)\
\-\ 8\\:\\ 0\\.0068126173949879494\ \(0\)\
\-\ breath\\:\\ 0\\.0068126173949879494\ \(0\)\
\-\ laboratory\\:\\ 0\\.006714481313121676\ \(0\)\
\-\ intact\\:\\ 0\\.006692461879953553\ \(0\)\
\-\ sinus\\:\\ 0\\.006663451960858076\ \(0\)\
\-\ wbc\\:\\ 0\\.006641950640886593\ \(0\)\
\-\ including\\:\\ 0\\.006578717784633099\ \(0\)\
\-\ typically\\:\\ 0\\.006431611448840026\ \(0\)\
\-\ signs\\:\\ 0\\.006412315424277302\ \(0\)\
\-\ or\\:\\ 0\\.006406328884629259\ \(0\)\
\-\ neoplasm\\:\\ 0\\.006205024682114985\ \(0\)\
\-\ inferior\\:\\ 0\\.006181911218249601\ \(0\)\
\-\ 10\\:\\ 0\\.006142055923980619\ \(0\)\
\-\ left\\:\\ 0\\.006115811956969604\ \(0\)\
\-\ palpation\\:\\ 0\\.0060808935615097055\ \(0\)\
\-\ along\\:\\ 0\\.00602143683765142\ \(0\)\
\-\ density\\:\\ 0\\.005994949588187546\ \(0\)\
\-\ days\\:\\ 0\\.005584380162413598\ \(0\)\
\-\ tenderness\\:\\ 0\\.005541390880344634\ \(0\)\
\-\ to\\:\\ 0\\.005463557890528609\ \(0\)\
\-\ artery\\:\\ 0\\.005425437083386352\ \(0\)\
\-\ abdomen\\:\\ 0\\.005397407810012146\ \(0\)\
\-\ primary\\:\\ 0\\.005397407810012146\ \(0\)\
\-\ in\\:\\ 0\\.005391009340813496\ \(0\)\
\-\ lung\\:\\ 0\\.0052775247766284564\ \(0\)\
\-\ ct\\:\\ 0\\.005097243724486324\ \(0\)\
\-\ however\\:\\ 0\\.005073279436241088\ \(0\)\
\-\ an\\:\\ 0\\.005039082576907163\ \(0\)\
\-\ are\\:\\ 0\\.004967479200552673\ \(0\)\
\-\ been\\:\\ 0\\.004956918740861388\ \(0\)\
\-\ up\\:\\ 0\\.004899460876448237\ \(0\)\
\-\ mild\\:\\ 0\\.00479798177810477\ \(0\)\
\-\ common\\:\\ 0\\.00476816036664477\ \(0\)\
\-\ patients\\:\\ 0\\.004715510872848669\ \(0\)\
\-\ for\\:\\ 0\\.004663804788759372\ \(0\)\
\-\ increased\\:\\ 0\\.004457323628570695\ \(0\)\
\-\ pain\\:\\ 0\\.004450354658979679\ \(0\)\
\-\ \\;\\:\\ 0\\.004318595284547108\ \(0\)\
\-\ associated\\:\\ 0\\.004299493735410878\ \(0\)\
\-\ 3\\:\\ 0\\.004266472338393475\ \(0\)\
\-\ \\%\\:\\ 0\\.004250151457027735\ \(0\)\
\-\ were\\:\\ 0\\.004137071080362305\ \(0\)\
\-\ well\\:\\ 0\\.0041217077888457375\ \(0\)\
\-\ present\\:\\ 0\\.0041151572578500654\ \(0\)\
\-\ contrast\\:\\ 0\\.004078412978268455\ \(0\)\
\-\ case\\:\\ 0\\.003986150176689277\ \(0\)\
\-\ large\\:\\ 0\\.003984099001772025\ \(0\)\
\-\ lateral\\:\\ 0\\.003937458519455331\ \(0\)\
\-\ 2\\:\\ 0\\.003923463745225045\ \(0\)\
\-\ seen\\:\\ 0\\.003600485319973753\ \(0\)\
\-\ also\\:\\ 0\\.0035919394321325187\ \(0\)\
\-\ has\\:\\ 0\\.0034215351183246863\ \(0\)\
\-\ \\(\\:\\ 0\\.0030804338006134775\ \(0\)\
\-\ \\)\\:\\ 0\\.003042804657199595\ \(0\)\
\-\ disease\\:\\ 0\\.0029781184247669595\ \(0\)\
\-\ the\\:\\ 0\\.0029477459425080125\ \(0\)\
\-\ as\\:\\ 0\\.002756028797215624\ \(0\)\
\-\ not\\:\\ 0\\.002632875632712016\ \(0\)\
\-\ at\\:\\ 0\\.002468578151026936\ \(0\)\
\-\ is\\:\\ 0\\.002397828479252561\ \(0\)\
\-\ and\\:\\ 0\\.0019190725557805804\ \(0\)\
\-\ patient\\:\\ 0\\.0018264220275402729\ \(0\)\
\-\ of\\:\\ 0\\.0017388626984774392\ \(0\)\
\-\ on\\:\\ 0\\.0015434776383058168\ \(0\)\
\-\ \\.\\:\\ 0\\.0015138394924241482\ \(0\)\
\-\ with\\:\\ 0\\.0014968551312139412\ \(0\)\
